New evidence on stemming low-value prescribing. | AHRQ Patient Safety Network

New evidence on stemming low-value prescribing. | AHRQ Patient Safety Network

• Commentary
 
• Published April 2019

New evidence on stemming low-value prescribing.

Sacarny A, Barnett ML, Agrawal S. NEJM Catalyst. April 10, 2019.

Overprescribing contributes to polypharmacy, antibiotic resistance, and opioid misuse. This commentary discusses strategies to change prescriber behavior such as peer comparisons and opioid overdose letters to prescribers whose patients recently overdosed to drive improvement and reflection.

Free full text

Related Resources

JOURNAL ARTICLE › STUDY

Association of opioid prescriptions from dental clinicians for US adolescents and young adults with subsequent opioid use and abuse.

Schroeder AR, Dehghan M, Newman TB, Bentley JP, Park KT. JAMA Intern Med. 2019;179:145-152.

JOURNAL ARTICLE › STUDY

Association of the use of a mandatory prescription drug monitoring program with prescribing practices for patients undergoing elective surgery.

Stucke RS, Kelly JL, Mathis KA, Hill MV, Barth RJ. JAMA Surg. 2018;153:1105-1110.

JOURNAL ARTICLE › REVIEW

Interventions for postsurgical opioid prescribing: a systematic review.

Wetzel M, Hockenberry J, Raval MV. JAMA Surg. 2018;153:948-954.

JOURNAL ARTICLE › STUDY

Opioid prescribing decreases after learning of a patient's fatal overdose.

Doctor JM, Nguyen A, Lev R, et al. Science. 2018;361:588-590.

JOURNAL ARTICLE › REVIEW

Labeling morphine milligram equivalents on opioid packaging: a potential patient safety intervention.

Stone AB, Urman RD, Kaye AD, Grant MC. Curr Pain Headache Rep. 2018;22:46.

View More